Fisetin alleviates lipopolysaccharide-induced mastitis by inhibiting ferroptosis and modulating the gut microbiota - PubMed
4 hours ago
- #Bovine mastitis
- #Ferroptosis
- #Gut microbiota
- Fisetin (FIS) shows potential in treating bovine mastitis by reducing inflammation and oxidative stress.
- FIS inhibits ferroptosis pathways, lowering inflammatory cytokines in mammary tissues.
- Treatment with FIS alters gut microbiota and increases short-chain fatty acids (SCFAs), aiding mastitis recovery.
- The study suggests FIS as a novel, antibiotic-free therapeutic strategy for mastitis.